Key facts
- This page summarizes Paul Hideo Opgenorth's Form 4 filing for EXOZYMES INC. (EXOZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Apr 2026, 06:23.
Paul Hideo Opgenorth - 01 Apr 2026 Form 4 Insider Report for EXOZYMES INC. (EXOZ)
- Reporting relationship
- Vice President, Development
- Issuer ticker
- EXOZ
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Apr 2026, 06:23:22 UTC
- Prior SEC filing
- 17 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Opgenorth
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Paul Hideo Opgenorth filed Form 4 for EXOZYMES INC. (EXOZ) on 08 Apr 2026.
Change
- Previous filing in this sequence was filed on 17 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002033517
Primary reporting owner
Opgenorth Paul Hideo
- Relationship
- Vice President, Development
- Address
- C/O 750 ROYAL OAKS DRIVE, SUITE 106, MONROVIA
- Signature
- /s/ Paul Opgenorth
- Signature date
- 07 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXOZ
transaction
COMMON STOCK
Award
- Transaction value
- Shares
- +3,999
- Change %
- +0.62%
- Price
- $8.44*
- Shares after
- 645,149
- Date
- 01 Apr 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Paul Hideo Opgenorth is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.